AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 152 min read$SNPS

Glaser Shelagh sold $1.5M of SNPS (indirect holdings)

Glaser Shelagh (CFO) sold 3,394 indirectly-held shares of SYNOPSYS INC (SNPS) at $450.02 ($1.53M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Glaser Shelagh
Published Jun 15, 2026, 6:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 6:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
high confidence
Mentioned
$SNPS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

A senior officer’s open-market sale is disclosed with transaction size, price, and post-transaction holdings; no new operating or market-moving information is provided.

02

Market read

Primarily a sentiment/positioning datapoint; likely limited incremental impact versus broader company fundamentals.

03

What to watch

Traders may over-weight insider sales; without changes in guidance, contracts, or regulatory developments, the signal is usually weak.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-15; transaction dated 2026-06-12.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Synopsys.

Company-level read

Ticker impact

$SNPSNeutralHigh confidence
Context

Synopsys CFO Glaser Shelagh filed an SEC Form 4 selling 3,394 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and no accompanying fundamental catalyst (no guidance, deal, or regulatory action).

Market effects

Sector

Minimal; insider selling at a single software name rarely changes sector fundamentals.

Regional

Minimal; no cross-asset or macro linkage stated.

Global

Minimal; transaction is company-specific and not tied to global events.

Counterpoint

What could challenge this read

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.

Key entities

  • issuer
    Synopsys

    Company whose CFO filed the Form 4 insider sale disclosure.

  • insider
    Glaser Shelagh

    CFO reporting an open-market sale of SNPS shares under a 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNPS insider trading history →

Related articles

OCT 27
$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

finance.yahoo.com2 min
OCT 26
$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

investing.com2 min
OCT 22
$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

echo.ie2 min
OCT 20
$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

finimize.com2 min